164 related articles for article (PubMed ID: 35165262)
21. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
[TBL] [Abstract][Full Text] [Related]
22. Polyene phosphatidylcholine overcomes oxaliplatin resistance in human gastric cancer BGC823 cells.
Zhang H; Song H; Yuan R; Zhang X; Yu H; Zhao Y; Jiang T
Biochem Biophys Res Commun; 2018 Feb; 497(1):108-114. PubMed ID: 29421658
[TBL] [Abstract][Full Text] [Related]
23. KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1.
Lin H; Yang G; Yu J; Wang J; Li Q; Guo S; Cao B
Biomed Pharmacother; 2018 Nov; 107():1205-1209. PubMed ID: 30257334
[TBL] [Abstract][Full Text] [Related]
24. siRNA-mediated silencing of MDR1 reverses the resistance to oxaliplatin in SW480/OxR colon cancer cells.
Montazami N; Kheir Andish M; Majidi J; Yousefi M; Yousefi B; Mohamadnejad L; Shanebandi D; Estiar MA; Khaze V; Mansoori B; Baghbani E; Baradaran B
Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):98-103. PubMed ID: 26025411
[TBL] [Abstract][Full Text] [Related]
25. Linc01559 Served as a Potential Oncogene and Promoted Resistance of Hepatocellular Carcinoma to Oxaliplatin by Directly Sponging miR-6783-3p.
Dong S; Fu Y; Yang K; Zhang X; Miao R; Long Y; Liu C
Anticancer Agents Med Chem; 2021; 21(2):278-286. PubMed ID: 32698745
[TBL] [Abstract][Full Text] [Related]
26. HIF-1α inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoprotein.
Chen J; Ding Z; Peng Y; Pan F; Li J; Zou L; Zhang Y; Liang H
PLoS One; 2014; 9(6):e98882. PubMed ID: 24901645
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.
Wang X; Ghareeb WM; Zhang Y; Yu Q; Lu X; Huang Y; Huang S; Sun Y; Chi P
J Cell Physiol; 2019 Aug; 234(10):18180-18191. PubMed ID: 30859572
[TBL] [Abstract][Full Text] [Related]
28. Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer.
Dong Y; Wang Z; Xie GF; Li C; Zuo WW; Meng G; Xu CP; Li JJ
Mol Cancer; 2017 Mar; 16(1):71. PubMed ID: 28356150
[TBL] [Abstract][Full Text] [Related]
29. DNAJB8 oligomerization is mediated by an aromatic-rich motif that is dispensable for substrate activity.
Ryder BD; Ustyantseva E; Boyer DR; Mendoza-Oliva A; Kuska MI; Wydorski PM; Macierzyńska P; Morgan N; Sawaya MR; Diamond MI; Kampinga HH; Joachimiak LA
Structure; 2024 Jun; 32(6):662-678.e8. PubMed ID: 38508190
[TBL] [Abstract][Full Text] [Related]
30. Improvement of resistance to oxaliplatin by vorinostat in human colorectal cancer cells through inhibition of Nrf2 nuclear translocation.
Tanaka S; Hosokawa M; Tatsumi A; Asaumi S; Imai R; Ogawara KI
Biochem Biophys Res Commun; 2022 Jun; 607():9-14. PubMed ID: 35358872
[TBL] [Abstract][Full Text] [Related]
31. The involvement of Aurora-A and p53 in oxaliplatin-resistant colon cancer cells.
Chen MC; Yang BZ; Kuo WW; Wu SH; Wang TF; Yeh YL; Chen MC; Huang CY
J Cell Biochem; 2023 Apr; 124(4):619-632. PubMed ID: 36976911
[TBL] [Abstract][Full Text] [Related]
32. [Effects of medicated serum prepared with Chinese herbal medicine Changweiqing on pharmacokinetics of oxaliplatin in colon cancer cells].
Zhang Y; Sun XW; Xu JH; Lu H; Fan ZZ; Sun J; Zhang XX
Zhong Xi Yi Jie He Xue Bao; 2012 Aug; 10(8):901-10. PubMed ID: 22883407
[TBL] [Abstract][Full Text] [Related]
33. miR-33a-5p in small extracellular vesicles as non-invasive biomarker for oxaliplatin sensitivity in human colorectal cancer cells.
Tanaka S; Hosokawa M; Miyamoto T; Nakagawa A; Haruna M; Ueda K; Iwakawa S; Ogawara KI
Biochem Biophys Rep; 2021 Jul; 26():100996. PubMed ID: 33898768
[TBL] [Abstract][Full Text] [Related]
34. Gene and protein expression in the oxaliplatin-resistant HT29/L-OHP human colon cancer cell line.
Xiang Z; Kang QJ; Xiang X
Genet Mol Res; 2015 Sep; 14(3):11013-22. PubMed ID: 26400331
[TBL] [Abstract][Full Text] [Related]
35. miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.
Wu YZ; Lin HY; Zhang Y; Chen WF
J Gene Med; 2020 Jul; 22(7):e3178. PubMed ID: 32092782
[TBL] [Abstract][Full Text] [Related]
36. MiR-153-5p promotes sensibility of colorectal cancer cells to oxaliplatin via targeting Bcl-2-mediated autophagy pathway.
He Y; Zhang L; Tan F; Wang LF; Liu DH; Wang RJ; Yin XZ
Biosci Biotechnol Biochem; 2020 Aug; 84(8):1645-1651. PubMed ID: 32380907
[TBL] [Abstract][Full Text] [Related]
37. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.
Zhu MM; Tong JL; Xu Q; Nie F; Xu XT; Xiao SD; Ran ZH
PLoS One; 2012; 7(8):e41763. PubMed ID: 22870247
[TBL] [Abstract][Full Text] [Related]
38. HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells.
Nishizawa S; Hirohashi Y; Torigoe T; Takahashi A; Tamura Y; Mori T; Kanaseki T; Kamiguchi K; Asanuma H; Morita R; Sokolovskaya A; Matsuzaki J; Yamada R; Fujii R; Kampinga HH; Kondo T; Hasegawa T; Hara I; Sato N
Cancer Res; 2012 Jun; 72(11):2844-54. PubMed ID: 22552285
[TBL] [Abstract][Full Text] [Related]
39. Taxol-Resistant Gene 1 (Txr1) Mediates Oxaliplatin Resistance by Inducing Autophagy in Human Nasopharyngeal Carcinoma Cells.
Chi HM; Du JD; Cheng J; Mao HD
Med Sci Monit; 2019 Jan; 25():475-483. PubMed ID: 30650069
[TBL] [Abstract][Full Text] [Related]
40. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G
J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
